The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(R)-pyrrolidin-2-ylmethyl 4-((4-(4-cyano-2-methylphenyl)piperidin-1-ylsulfonyl)methyl)-4-(hydroxycarbamoyl)piperidine-1-carboxylate ID: ALA253230
PubChem CID: 11713686
Max Phase: Preclinical
Molecular Formula: C26H37N5O6S
Molecular Weight: 547.68
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: Cc1cc(C#N)ccc1C1CCN(S(=O)(=O)CC2(C(=O)NO)CCN(C(=O)OC[C@H]3CCCN3)CC2)CC1
Standard InChI: InChI=1S/C26H37N5O6S/c1-19-15-20(16-27)4-5-23(19)21-6-11-31(12-7-21)38(35,36)18-26(24(32)29-34)8-13-30(14-9-26)25(33)37-17-22-3-2-10-28-22/h4-5,15,21-22,28,34H,2-3,6-14,17-18H2,1H3,(H,29,32)/t22-/m1/s1
Standard InChI Key: RMPKUSBLGZHQII-JOCHJYFZSA-N
Molfile:
RDKit 2D
38 41 0 0 1 0 0 0 0 0999 V2000
3.8405 -1.7833 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2633 -2.4917 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.0837 -2.4797 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
4.2380 -1.0629 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.9732 -2.5509 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.3705 -1.8278 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.9430 -1.1222 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.1953 -1.8104 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.6204 -2.5214 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.4416 -2.5060 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.4165 -1.0772 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5890 -1.0911 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.9061 -2.4635 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.0979 -3.3046 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.0675 -1.6549 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.0628 -1.0470 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.8117 -0.3566 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.2103 0.3657 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.3301 -3.1694 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.1490 -3.1552 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.5500 -2.4367 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.1259 -1.7307 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.3009 -1.7434 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.3729 -2.4244 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.7961 -3.1339 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.6203 -3.1211 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.0222 -2.3996 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.5938 -1.6895 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.7711 -1.7057 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.3453 -0.9991 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.1484 -2.5683 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.2489 -3.2913 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0702 -3.3995 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2246 -4.2099 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.5015 -4.6073 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0996 -4.0423 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
10.8457 -2.3832 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.6706 -2.3689 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5 6 1 0
1 4 1 0
8 12 1 0
9 10 1 0
10 1 1 0
13 23 1 0
19 20 1 0
20 21 1 0
21 22 1 0
22 23 1 0
1 11 1 0
11 12 1 0
24 25 2 0
6 7 2 0
25 26 1 0
3 13 1 0
26 27 2 0
2 3 1 0
27 28 1 0
3 14 2 0
28 29 2 0
29 24 1 0
21 24 1 0
6 8 1 0
29 30 1 0
3 15 2 0
5 31 1 0
8 9 1 0
32 31 1 6
32 33 1 0
4 16 2 0
4 17 1 0
1 2 1 0
33 34 1 0
34 35 1 0
35 36 1 0
36 32 1 0
17 18 1 0
13 19 1 0
37 38 3 0
27 37 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 547.68Molecular Weight (Monoisotopic): 547.2465AlogP: 1.85#Rotatable Bonds: 7Polar Surface Area: 152.07Molecular Species: BASEHBA: 8HBD: 3#RO5 Violations: 1HBA (Lipinski): 11HBD (Lipinski): 3#RO5 Violations (Lipinski): 2CX Acidic pKa: 8.81CX Basic pKa: 10.31CX LogP: -0.32CX LogD: -1.50Aromatic Rings: 1Heavy Atoms: 38QED Weighted: 0.35Np Likeness Score: -0.78
References 1. Burns DM, He C, Li Y, Scherle P, Liu X, Marando CA, Covington MB, Yang G, Pan M, Turner S, Fridman JS, Hollis G, Vaddi K, Yeleswaram S, Newton R, Friedman S, Metcalf B, Yao W.. (2008) Conversion of an MMP-potent scaffold to an MMP-selective HER-2 sheddase inhibitor via scaffold hybridization and subtle P1' permutations., 18 (2): [PMID:18068976 ] [10.1016/j.bmcl.2007.11.086 ]